UBRELVY 100 mg/1

UBRELVY 100 mg tablets contain ubrogepant, a medication used for acute migraine treatment. This oral tablet is designed to provide relief from migraine headaches. Ubrogepant is a selective calcitonin gene-related peptide (CGRP) receptor antagonist.

UBRELVY 100 mg tablets are primarily used for the acute treatment of migraine headaches with or without aura in adults. Ubrogepant works by blocking the activity of CGRP, a molecule involved in migraine attacks. This medication is not intended for preventive use or for other types of headaches.

Common effects of Ubrevly 100 mg tablets may include nausea, fatigue, and dry mouth. Some users may experience dizziness or somnolence. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare provider.

UBRELVY 100 mg tablets should be used with caution in individuals with liver impairment. It is important to follow the prescribed dosage and administration instructions. This medication should be stored at room temperature, away from moisture and heat. Keep out of reach of children.

UBRELVY 100 mg tablets may interact with other medications, including strong CYP3A4 inducers and inhibitors. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using this medication.